相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder
Hiroshi Miyamoto et al.
BJU INTERNATIONAL (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy
Daniela Gallo et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Differential Role of Estrogen Receptor Beta in Early Versus Metastatic Non-small Cell Lung Cancer
Navaratnam et al.
HORMONES & CANCER (2012)
Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2
Sreenivasan Paruthiyil et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Lower Risk in Parous Women Suggests That Hormonal Factors Are Important in Bladder Cancer Etiology
Carol A. Davis-Dao et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
A Framework to Select Clinically Relevant Cancer Cell Lines for Investigation by Establishing Their Molecular Similarity with Primary Human Cancers
Garrett M. Dancik et al.
CANCER RESEARCH (2011)
Parity, early menopause and the incidence of bladder cancer in women: A case-control study and meta-analysis
K. Dietrich et al.
EUROPEAN JOURNAL OF CANCER (2011)
Crosstalk Between Estrogen Receptor and Mitogen-Activated Protein Kinase Signaling in the Development and Progression of Endometrial Cancer
Long Zhou et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Evaluation of Cell Cycle Arrest in Estrogen Responsive MCF-7 Breast Cancer Cells: Pitfalls of the MTS Assay
Eileen M. McGowan et al.
PLOS ONE (2011)
The different roles of ER subtypes in cancer biology and therapy
Christoforos Thomas et al.
NATURE REVIEWS CANCER (2011)
Sex Differences in Estrogen Receptor Subcellular Location and Activity in Lung Adenocarcinoma Cells
Margarita M. Ivanova et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Inverse expression of estrogen receptor-β and nuclear factor-κB in urinary bladder carcinogenesis
Stylianos Kontos et al.
INTERNATIONAL JOURNAL OF UROLOGY (2010)
Ligand-Independent Antiapoptotic Function of Estrogen Receptor-β in Lung Cancer Cells
GuangFeng Zhang et al.
MOLECULAR ENDOCRINOLOGY (2010)
Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols
Piwen Wang et al.
PLOS ONE (2010)
Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-α and the REA corepressor
Sudipan Karmakar et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells
Pamela A. Hershberger et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Estrogen and Progesterone Receptor Expression is not Always Specific for Mammary and Gynecologic Carcinomas A Tissue Microarray and Pooled Literature Review Study
Shi Wei et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2009)
Roles of estrogen receptor α and β in modulating urothelial cell proliferation
Jian Teng et al.
ENDOCRINE-RELATED CANCER (2008)
Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues
A. Morani et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cells
Jack-Michel Renoir et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2008)
The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor α transcriptional activity
Theresa J. Peterson et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma
Guru Sonpavde et al.
UROLOGY (2007)
Reproductive risk factors for incident bladder cancer: Iowa Women's Health Study
Anna E. Prizment et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Defining optimal therapy for muscle invasive bladder cancer
Harry W. Herr et al.
JOURNAL OF UROLOGY (2007)
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial
Victor G. Vogel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Expression of estrogen receptors-α and -β in bladder cancer cell lines and human bladder tumor tissue
Steven S. Shen et al.
CANCER (2006)
Functional estrogen receptors in the mitochondria of breast cancer cells
A Pedram et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study
B Fisher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Toxic proteins released from mitochondria in cell death
X Saelens et al.
ONCOGENE (2004)
Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin
S Mabuchi et al.
ENDOCRINOLOGY (2004)
The health economics of bladder cancer - A comprehensive review of the published literature
MF Botteman et al.
PHARMACOECONOMICS (2003)
A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years
P Larsson et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2003)
Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death
M Obrero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells
HT Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Opposing action of estrogen receptors α and β on cyclin D1 gene expression
MM Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of estrogen receptor α and β mRNAs in prostate cancers treated with leuprorelin acetate
S Maruyama et al.
EUROPEAN UROLOGY (2000)
Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells
S Cariou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Estrogen receptor β mRNA in colon cancer cells:: Growth effects of estrogen and genistein
N Arai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
H Walczak et al.
EXPERIMENTAL CELL RESEARCH (2000)
Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription
D Guardavaccaro et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
